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Abstract
Purpose: Mismatches between pre- and post-natal environments have implications for disease in adulthood. However, less
is known about how this mismatch can affect physiological systems more generally, especially at younger ages. We
hypothesised that mismatches between pre- and post-natal environments, as measured by the measures of birthweight
and adult leg length, would be associated with poorer biomarker levels across five key physiological systems in young
adults.
Methods: Data were collected from 923, 36 year-old respondents from the West of Scotland Twenty-07 Study. The
biomarkers were: systolic blood pressure (sBP); forced expiratory volume (FEV1); glycated haemoglobin (HbA1c); glomerular
filtration rate (eGFR); and gamma-glutamyltransferase (GGT). These biomarkers were regressed against pre-natal conditions
(birthweight), post-natal conditions (leg length) and the interaction between pre- and post-natal measures. Sex, childhood
socioeconomic position and adult lifestyle characteristics were adjusted for as potential effect modifiers and confounders,
respectively.
Results: There were no associations between birthweight and leg length and sBP, FEV1, HbA1c, or GGT. Higher birthweight
and longer leg length were associated with better kidney function (eGFR). However, there was no evidence for mismatches
between birthweight and leg length to be associated with worse sBP, FEV1, HbA1c, eGFR or GGT levels (P.0.05).
Conclusions: Our hypothesis that early signs of physiological damage would be present in young adults given mismatches
in childhood environments, as measured by growth markers, was not proven. This lack of association could be because age
36 is too young to identify significant trends for future health, or the associations simply not being present.
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Introduction
The foetal origins of disease have been widely studied, with pre-
natal growth (often measured through birthweight and used as a
marker for the uterine developmental environment) consistently
linked with the later development of adult disease [1]. However,
there is mounting evidence that the association between pre-natal
development and later health is strengthened when post-natal
conditions are considered. Typically, poorer growth in utero (as a
result of, for example, poor nutrition, maternal smoking/alcohol
consumption or maternal stress) [2] followed by rapid growth in
childhood (as a result of, for example, increased nutrition, reduced
stress or decreased infections) [3] appears to have the greatest
detrimental effect on health [4–7]. Although there is increasing
evidence of the implications for disease in adulthood following
such plasticity in growth brought about by mismatches in
environmental circumstances, less is known about how mismatches
could affect the physiological systems in the body more generally,
especially at younger ages. This relationship is important as it
could improve not only our understanding of the early-life
influences on disease process, but also enable earlier intervention
prior to the onset of disease.
The aim of this study was to examine the influence of
mismatches between pre- and post-natal conditions across five
key physiological systems important to health and functioning.
The biomarkers selected were: systolic blood pressure (sBP;
circulatory system); forced expiratory volume in one second
(FEV1; respiratory system/lung function); glycated haemoglobin
(HbA1c; metabolic system/diabetes marker); estimated glomerular
filtration rate (eGFR; excretory system/kidney function); and
gamma-glutamyltransferase (GGT; hepatic system/liver function).
We chose to focus on young adults to identify effects prior to the
onset of disease.
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Our hypothesis was that mismatches between birthweight and
leg length (marker of post-natal childhood environment and
growth [8–10]) would be associated with more negative biomarker
outcomes, with the association strongest with GGT given that the
liver is one of the most plastic organs after birth [5]. There is
evidence that post-natal conditions continue to influence sBP
[11,12] and HbA1c [11,13]. We predicted that there would be an
association between those respondents showing mismatches
between pre- and post-natal conditions and these two biomarkers,
although weaker than that seen with GGT (due to their reduced
plasticity in childhood). The evidence for an association between
mismatches between pre- and post-natal conditions and FEV1 is
weaker than for BP and HbA1c [14,15]. Therefore it was predicted
that mismatches between pre- and post-natal conditions would be
only weakly associated with FEV1. It was predicted that eGFR
would not be associated with mismatches between pre- and post-
natal conditions given that kidney development is complete prior
to birth [16,17].
Methods
Study Sample
The West of Scotland Twenty-07 Study is a community-based,
prospective cohort study started in 1987 and completed in 2007/8.
Individuals were recruited using a clustered randomised sample
design in the greater Glasgow area in the West of Scotland, UK.
Respondents were aged 36 years at blood sampling (wave 5 of data
collection). The baseline sample consisted of 1515 respondents
(777 women). Due to attrition, the sample size by wave 5 was 923
(505 women). Data were collected by trained nurses in partici-
pants’ homes. More detail about the study is available elsewhere
[18].
Main Outcome Measures
Systolic BP (mmHg) was measured using a sphygmomanometer
(Omron Healthcare UK Ltd., West Sussex, UK). The mean values
of two readings from the same arm were used.
FEV1 (litres/second) was measured using a vitalograph (Micro
Plus Spirometer MS03; Micro Medical, Rochester, UK). The
highest value of three readings was used, standardised by dividing
by height squared [19]. Serum creatinine (mmol/l) was measured
using the Kinetic Jaffe method (list number 7D64, Abbott
Diagnostics, Abbott, Illinois, USA). Creatinine was standardised
to produce eGFR (ml/min) using the Cockcroft-Gault method
[20]. Serum GGT (units/litre) was measured using the carboxyl
nitroanilide (IFCC) method (list number 7D65, Abbott Diagnos-
tics). Whole blood HbA1c (%) was measured using an HPLC auto-
analyser method (HA-8160; Menarini, Rungis, France). In
analyses using BP and HbA1c, we identified the need to employ
adjustments to the statistical models to address potential modifying
effects of medications on biomarkers. For those respondents using
anti-hypertensive (n = 24) or anti-diabetes (n = 7) medications we
included dummy variables for medication use in the statistical
models [21] [22]. As a sensitivity test, we also excluded these
individuals from the analysis. The results were unchanged.
Growth Measures
The parents of respondents were asked at baseline to recall the
birthweight (kg) of the respondent. Leg length was derived from
subtracting sitting height (cm) from standing height (cm) at age 36,
both measured using a Seca Leicester stadiometer (Cranlea,
Birmingham, UK). Each growth marker was standardised using
sex-specific z-scores prior to analysis.
Lifestyle Factors and Socioeconomic Position
Lifestyle factors can alter the physiology and biomarker levels of
people throughout their lives. Given this potential for confounding
the association between early-life factors and later biomarker
measures, we chose to adjust for alcohol and smoking consump-
tion, as well as obesity and physical activity. Data on alcohol
consumption (units/week), smoking status (‘current’, ‘ex’ or ‘never’
smoker), Body Mass Index (BMI) and physical activity (hours of
moderate or vigorous activity/week) were collected at wave 5.
Childhood socioeconomic position (SEP) is linked with both
birthweight and growth in childhood, with lower SEP children
showing lower birthweight [23], but greater levels of compensa-
tory/catch-up growth in early childhood [24]. In addition, SEP is
strongly linked with disparities in adult health and physiological
functioning [25]. Hence, we also investigated childhood SEP as a
potential effect modifier through stratified analysis, using occupa-
tion-based social class at birth (Registrar General’s Social Class).
The highest ranking occupation between the two parents was
selected.
Statistical Analysis
A total of 768 respondents had complete data for birthweight,
leg length, parental occupation and the lifestyle characteristics. All
768 respondents had their blood pressure recorded, but only 749
had FEV1 measured. 644 respondents provided blood samples
suitable for measurement of HbA1c, with 643 providing eGFR and
GGT results. The total amount of missing data across all measures
was 6% for those taking part in wave 5 and 31% when all those
respondents who were in the study at baseline were considered.
Multiple imputation (MI) was used to address potential biases
arising from missing data values. Twenty five imputed datasets
were created. Imputation and analyses were performed using the
‘ice’ and ‘mim’ packages in Stata (ver.11, Stata Corp., Texas,
USA). In addition to all variables used in the analyses, auxiliary
variables (those not included in the analysis, but which help predict
missingness) were also included in the imputation model. These
included ‘any chronic illness’ and ‘self-rated health’ at wave 5, and
‘mother’s religion’, ‘whether breastfed’, ‘any birth complications’
and ‘any limiting longstanding illness in the household’ at wave 1.
Linear regression was used for the statistical analyses, with all
analyses adjusted for clustered sampling at baseline and were
weighted to the living baseline sample at the time of the wave 5
interviews using inverse probability weights to correct for bias due
to drop out [26]. These weights were also included in the
imputation model. Separate analyses were run for each biomarker.
For clearer interpretation of the results, higher levels of all five
biomarkers reflect poorer functioning. For FEV1 and eGFR,
results were multiplied by 21 prior to regression analysis to reflect
this. The initial (‘unadjusted’) models included: birthweight, leg
length and birthweight*leg length (used to assess the mismatch
between pre- and post-natal growth measures [27]), all assessed as
continuous variables; sex; and birth status (singleton or twin). The
‘adjusted’ models additionally included the adult lifestyle factors.
The different lifestyle confounders were tested separately, although
only the fully adjusted models (all confounders included) are
presented due to a lack of substantive differences compared to the
single-confounder models. Sub-sample analyses, stratifying by sex
and SEP, were also run to investigate possible effect modification,
but again showed no substantive differences compared to the full
models. All analyses were weighted to the living baseline sample at
the time of the wave 5 interviews using inverse probability weights
to correct for bias due to drop out [26].
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Sensitivity Analysis
Categorical versions of birthweight and leg length were also
considered in order to capture more extreme cases of the
mismatch between pre- and post-natal growth. Birthweight was
categorised as low (,2.5 kg), average (2.5–3.9 kg) or high
(.3.9 kg), while leg length was converted into sex-specific tertiles.
Regression analyses using a nine-category variable were employed,
with those showing low birthweight and long leg length used as the
reference category.
Ethical Approval
Ethical approval for the baseline study was granted in 1986 by
the GP Sub-Committee of Greater Glasgow Health Board and the
ethics sub-committee of the West of Scotland Area Medical
Committees. Wave 5 was approved by the Tayside Committee on
Medical Research Ethics. Informed, written consent was obtained
from all respondents at each wave of the study. At wave 1 (when
aged 15), written consent was obtained from parents/guardians
and the respondents.
Results
The characteristics of the respondents sampled are shown in
Table 1. Birthweights were comparable to the national average in
1985 [28], as were lifestyle factors compared to national data from
2011 [29]. Biomarker values were largely below clinically-relevant
cut-offs. Analysis samples were similar to the complete wave 5
sample in terms of proportions within each category and mean
values (not presented). The results of the analyses are presented in
Table 2, where a significant negative coefficient represents a
scenario where small birthweight would have a greater effect only
in those with longer leg length [27]. A significant positive
interaction would suggest that increasing birthweight would have
a greater effect only in those with longer leg length. However,
there was no evidence that mismatches between pre- and post-
natal conditions were associated with any of the five biomarkers,
either before or after adjustment for adult lifestyle factors (Table 2).
Complete-case analysis results did not reveal any substantive
differences to those presented using MI (Table S1 in File S1).
Analysis of the individual growth markers (birthweight and leg
length) also failed to show any associations with sBP, FEV1, HbA1c
or GGT. However, higher birthweight was associated with better
kidney function (eGFR) (b=25.45, 95% CI: 28.53, 22.38), with
this association remaining after adjustment for lifestyle confound-
ers (b=22.95, 95% CI: 25.04, 20.87). Greater leg length was
also associated with better kidney function, but only after
adjustments (b=25.35, 95% CI: 27.89, 22.81). The results of
the sex and SEP-stratified analyses were no different from the full
analyses.
The sensitivity analysis using a nine-category version of growth
marker mismatches revealed that there were no consistent
associations with any of the five individual biomarkers Tables
S2a–S2e in File S1).
Discussion
This study found that mismatches between pre- and post-natal
conditions, represented as the interaction between birthweight and
leg length in adulthood, were not associated with worse
physiological functioning across the circulatory (sBP), respiratory
(FEV1), metabolic (HbA1c), excretory (eGFR) and hepatic (GGT)
systems in 36-year-old men and women from the West of
Scotland. These findings did not match our hypotheses for sBP,
Table 1. Study characteristics based on those taking part in
wave 5 (non-imputed).
Sample
size Mean (SD)
Sex 923
Male 418 (45.3%)
Female 505 (54.7%)
Missing 0 (0%)
Birthweight (kg) 877 3.31 (0.60)
Missing 46 (5.0%)
Leg length (cm) 906 79.52 (6.10)
Missing 17 (1.8%)
sBP (mmHg) 917 124.45 (15.87)
Missing 6 (0.7%)
FEV1 (litres/sec)/height
2 879 1.18 (0.19)
Missing 44 (4.8%)
HbA1c (%) 757 5.21 (0.49)
Missing 166 (18.0%)
eGFR (ml/minute) 752 116.00 (28.82)
Missing 171 (18.5%)
GGT (units/litre) 756 35.46 (39.76)
Missing 167 (18.1%)
Weekly alcohol consumption* 848
Not heavy drinker 592 (62.9%)
Heavy drinker 256 (27.2%)
Missing 93 (9.9%)
Smoking status 918
Never smoked 443 (47.1%)
Ex-smoker 217 (23.1%)
Current smoker 258 (27.4%)
Missing 23 (2.4%)
BMI 896
Underweight (,18.50) 12 (1.3%)
Normal range (18.50–24.99) 278 (29.5%)
Overweight (25.00–27.49) 356 (37.8%)
Obese ($30.00) 250 (26.6%)
Missing 45 (4.8%)
Weekly physical activity** 918
Below recommended levels* 556 (59.1%)
Meet or surpass recommended levels* 362 (38.5%)
Missing 23 (2.4%)
Social class at birth (SEP) 892
I (Professional etc. occupations) 84 (9.1%)
II (Managerial and technical occupations) 184 (19.9%)
III – NM (Non-manual skilled occupations) 345 (37.4%)
III – M (Manual skilled occupations) 178 (19.3%)
IV (Partly-skilled occupations) 92 (10.0%)
V (Unskilled occupations) 9 (1.0%)
Missing 31 (3.4%)
*Heavy drinker =more than 14 (women) or 21 (men) units per week.
**Based on the UK Departments of Health recommendations of 2.5 hours of
moderate or 1.25 hours of vigorous activity per week for 18–64 year olds.
doi:10.1371/journal.pone.0086953.t001
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HbA1c or GGT, although they did match our predictions for a
lack of association with FEV1/eGFR.
The evidence linking mismatches between pre- and post-natal
conditions and physiological functioning in early adulthood has
received limited attention. Of those studies that have investigated
the issue, there have been mixed findings brought about by: using
a mixture of definitions or methods for operationalising such
mismatches; focusing on disease outcomes; focusing solely on
either pre- or post-natal growth; incorrectly analysing the
interaction between the pre- and post-natal conditions [27];
testing only one biomarker/physiological system; and/or sampling
from older respondents only. A recent meta-analysis found that
mismatches between pre- and post-natal growth were associated
with increased blood pressure in adulthood [30]. Although there is
limited evidence for mismatches between pre- and post-natal
conditions, as assessed by growth patterns, being linked with
HbA1c, they have been linked with increased insulin resistance in
60–79 year-old British women having had low birthweight, but
high BMI in childhood [31]. In a study of British middle-aged
adults, increased birthweight and trunk length were found to be
independently associated with increased FEV1, although no
interaction was considered [14]. In a study of 60+ year-old British
women, increased leg length was associated with lower GGT levels
(better functioning). However, to the best of our knowledge, no
studies have considered the effects of mismatches between pre-
and post-natal growth on GGT. Studies investigating the links
between early-life conditions and kidney function/eGFR have
focused solely on birthweight due to the major development of the
kidney taking place prior to birth, although these have confirmed
that lower birthweight is associated with worse kidney outcomes
[32]. However, no studies to date have investigated the effects of
mismatches between pre- and post-natal growth/conditions on
biomarkers across multiple physiological systems.
Our hypothesis that early signs of physiological damage (leading
to diagnosable diseases later in life) would already be underway in
terms of detrimental effects on sBP, HbA1c and GGT levels in
young adults given mismatches between pre- and post-natal
conditions in childhood has not been confirmed. This lack of
association could be the result of several factors. Firstly, age 36
could be too young to identify significant alterations in these
biomarkers. Although most diseases linked to the physiological
systems represented in this study (such as diabetes and chronic
obstructive pulmonary disease (COPD)) do not manifest them-
selves until 40+ years of age [33], sBP [34,35], HbA1c [36,37] and
GGT [38,39] track well from childhood/adolescence through to
adulthood. FEV1 [40,41] and eGFR [42,43] are also known to
track well from early adulthood onwards. Given this lifecourse
tracking, we would expect biomarker levels at age 36 to be
predictors of biomarker levels (and disease risk) later in adulthood.
Secondly, there is the possibility that there truly is no effect of a
mismatch between pre- and post-natal conditions on the
biomarkers chosen. It was predicted that for eGFR, and FEV1
to a lesser extent, it was unlikely that we would see a significant
association with mismatches between pre- and post-natal condi-
tions. However, given the plasticity of GGT in particular, it is
surprising that no effect was identified for this biomarker. This
study has failed to show any evidence of links between either the
pre- or post-natal growth measures with the biomarkers, except for
a link between higher birthweight and lower eGFR levels (better
kidney function). However, it could be that either pre- or post-
natal factors are independent predictors of later outcomes, with
the mismatch between the two not being important.
Blood pressure is probably the most-studied of the five
biomarkers used here for its association with pre-and post-natal
growth conditions. There is good evidence for increased blood
pressure in those who have experienced growth mismatches in
childhood or adolescence (lower birthweight followed by increased
height or weight gain later in life) [30,44–46]. However, there is
some evidence that the association between birthweight and blood
pressure is not robust to confounding factors and is much weaker
than previously thought [47]. Indeed, we found no association
between birthweight and blood pressure at age 35. In previous
studies, lung function has also been found to be associated with
growth/environmental mismatches (catch-up growth from a lower
birthweight starting point) [48,49]. A recent meta-analysis also
suggested that a 1 kg increase in birthweight was associated with a
moderate increase in FEV1 (better lung function) [50]. Similar to
blood pressure though, this study found no evidence of such
associations. Early life factors relating to diabetes risk later in life
have been well studied. [13,51–54]. Forsen et al identified that low
birthweight, birth length, ponderal index (mass divided by height3)
and placenta weight were associated with increased risk of Type II
diabetes [13]. Although height and weight at age 7 were not
associated with an increased risk of the disease, rapid (catch-up)
growth between ages 7 and 15 and more so when birthweight was
low. Eriksson et al added to this by showing that rapid increases in
BMI in the first 2 years of life were associated with increased risk of
diabetes in adulthood (after age 40), although it was larger babies
who had experienced slower growth in the first few months of life
who had the greatest risk of the disease [52]. Mericq et al
Table 2. Regression results for the five biomarkers modelled
against birthweight and leg length.
Multiple imputation analysis (n= 923)
Unadjusted Adjusted
b 95% CI b 95% CI
BP - Birth weight 20.10 21.12, 0.92 20.57 21.58, 0.42
- Leg length 20.35 21.94, 1.25 0.66 20.74, 2.07
- Birth weight*
Leg length
0.41 20.49, 1.31 0.14 20.66, 0.94
FEV1 - Birth weight 20.02 20.03, 0.01 20.01 20.03, 0.01
- Leg length 20.01 20.02, 0.02 0.01 20.01, 0.03
- Birth weight*
Leg length
0.01 20.01, 0.02 0.01 20.01, 0.02
HbA1c - Birth weight 20.02 20.058, 0.03 20.03 20.08, 0.03
- Leg length 20.05 20.11, 0.01 0.04 20.10, 0.03
- Birth weight*
Leg length
0.01 20.04, 0.06 0.01 20.05, 0.06
eGFR - Birth weight 25.45 28.53,
22.38**
22.95 25.04, 20.87**
- Leg length 0.93 23.97, 2.11 25.35 27.89, 22.81**
- Birth weight*
Leg length
20.52 24.39, 3.35 20.30 22.28, 2.88
GGT - Birth weight 23.36 27.88, 2.33 23.82 27.70, 0.06
- Leg length 24.92 210.05, 1.17 23.32 28.81, 2.18
- Birth weight*
Leg length
0.12 23.96, 4.21 20.48 24.70, 3.75
*p#0.05;
**p#0.001.
Unadjusted: models include sex and birth status (singleton or twin).
Adjusted: models include unadjusted model plus: alcohol, smoking
consumption, BMI, physical activity.
doi:10.1371/journal.pone.0086953.t002
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investigated the association between small-for-gestational-age
(SGA) babies who showed catch-up growth by age 3 and fasting
insulin levels at birth and at age 3 [55]. They found that at birth,
SGA babies had lower insulin levels compared to average-for-
gestational-age (AGA) babies. However, by age 3 (and after
catching up to match the AGA babies), SGA babies had
significantly higher insulin levels. Again, our study could find no
matching associations. Low birthweight has been found to be
associated with reduced kidney size in infants and adults [56–58].
Schmidt et al showed that weight at 3 and 18 months of age was
positively associated with kidney volume, although there was no
evidence of mismatches impacting on kidney volume [58]. Animal
models of pre/post-natal mismatches in the form of catch-up
growth have shown there to be a ‘‘second hit’’ effect of this
plasticity on reducing nephron number [59]. Given that kidney
development is complete prior to birth, it is not surprising that no
association between the mismatch and eGFR was identified here.
However, as one would expect, larger birthweight was associated
with improved kidney function. Altered liver function has long
been proposed as a mechanism by which poor weight gain in utero
is associated with increased CHD risk [60–62] through increases
in serum cholesterol and plasma fibrinogen levels [61,63].
However, empirical evidence using biomarkers of liver function
are lacking.
The third possibility for a lack of association is that more
extreme cases of mismatches between pre- and post-natal growth
markers are needed to have a measurable effect. Our sensitivity
analysis using a categorical variable did not identify any consistent
associations with the five biomarkers. This indicates that more
extreme mismatches between pre- and post-natal growth are not
associated with more detrimental biomarker outcomes. This
stayed true even when adjusting for potential confounders,
showing the results to be robust.
Finally, a lack of statistical power is a potential issue. However,
the sample sizes used here are relatively large and should be
suitable for identifying statistically significant findings if they exist.
Using MI to address the potential for bias due to missing values
did not alter any of the results either. MI (and sample weights)
cannot fully address issues of selective drop-out however, so the
possibility that those individuals with the greatest growth
mismatch and/or biomarker scores are missing from wave 5 of
the sample must be considered.
In this study we have used a relatively large, community-based
cohort study, with a wide range of biomarkers across key
physiological systems. A further strength of the study is that
younger respondents at the age of 36 have been included, with
most studies typically focusing on middle- and older-aged adults.
This has allowed us to focus on physiological measures relatively
early on in adulthood and typically before the diagnosis of chronic
diseases. It is important that studies aim to identify the pathways
and precursors of disease, rather than focus on disease incidence in
mid-later life, in order to help identify at-risk individuals prior to
the onset of disease. However, our evidence suggests that even at
36 years of age it may be too early to identify physiological
consequences of early-life growth patterns (with individual
biomarkers at least).
Birthweight is both cheaply and easily measured, as well as
being possible to obtain many years after birth. However, it may
not represent the best measure for operationalising pre-natal
growth, with measures such as body composition and adiposity
perhaps more accurate [11,64,65]. This study has relied on
mothers’ recall of their babies’ birthweight and although not ideal,
it has been shown to be comparable to registration data [66]. We
also did not have any information regarding gestational age, which
could be important in determining if pre-term babies have a
distinct link with physiological outcomes in adulthood and if it is
these babies who composed our more extreme mismatched group.
Leg length represents growth throughout infancy and early
childhood [8,9], so may not be as accurate as a measure of
stature/length taken in the first year of life. However, measures of
stature were not available for the respondents as infants. Previous
studies have typically used BMI or other adiposity measures to
assess the interaction between pre- and post-natal conditions.
However, leg length can be measured in adulthood as a
retrospective measure of post-natal development, especially infant
nutrition [10]. In addition, it was not possible to measure BMI in
childhood in this sample as the study started when respondents
were 15 years old. A trade-off between having biomarker data
available in early adulthood and having measures of stature/
growth/adiposity during childhood was necessary. The biomark-
ers chosen were analysed as continuous measures and not
converted to clinically relevant (binary) cut-offs. This approach
was taken due to the age of the respondents, as most did not show
clinically relevant values to justify dichotomising. In addition, it
was important for this study that the biomarker measures reflected
physiological states prior to the onset of a diagnosable disease in
order to help predict disease risk earlier in life.
This study has failed to find a conclusive link between
mismatches in pre- and post-natal growth and physiological
dysregulation across five key bodily systems. However, this does
not mean that growth in childhood is not an important
determinant of health later in life. Future work could use models
of cumulative physiological burden such as allostatic load that
combine information across multiple systems in a synergistic
fashion [25]. In addition, studies that have more detailed growth
measures taken in childhood could also provide more robust
indicators of growth and plasticity than achieved here.
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